SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

SeaStar Medical (Nasdaq: ICU) will report first quarter 2026 financial results after market close on Wednesday, May 13, 2026.

Rhea-AI Summary

SeaStar Medical (Nasdaq: ICU) will report first quarter 2026 financial results after market close on Wednesday, May 13, 2026.

The company will host a webcast and conference call at 4:30 p.m. ET / 2:30 p.m. MT with preregistration required; a replay will be available after 7:30 p.m. ET.

Argus May 6 session

+10.18% close to close Open Argus

Details

News Market Reaction – ICU

On May 6, the day this news came out, ICU closed 10.18% above the previous close.

Data tracked by StockTitan Argus for the May 6 session.

Market Context

On May 6, the day this news came out, the stock closed 10.2% above the previous close. A strong posi...

Analysis

On May 6, the day this news came out, the stock closed 10.2% above the previous close. A strong positive reaction aligns with how SeaStar Medical has sometimes traded around key communications, such as prior earnings and clinical updates. Historically, the only comparable earnings date notice was followed by a -3.4% move, so a large gain would represent a departure from that pattern. Investors could compare the move to past earnings releases and monitor subsequent filings or capital markets activity for context on the sustainability of enthusiasm.

Key Figures

Earnings date: May 13, 2026 Conference call time: 4:30 p.m. ET Replay availability: After 7:30 p.m. ET

Earnings date

May 13, 2026

First quarter 2026 financial results to be reported after market close

Conference call time

4:30 p.m. ET

Start time for Q1 2026 webcast and conference call on May 13, 2026

Replay availability

After 7:30 p.m. ET

Replay of the Q1 2026 call available the same day

Previous Earnings date Reports

1 past event · Latest: Mar 18

Same Type 1 event

1. Mar 18

   Earnings date notice

   24h Move

   -3.4%

   Announced date and time for Q4 and full-year 2025 earnings call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 13, 2026, and host a webcast and conference call to discuss its financial results and business progress.

Date/Time:	Wednesday, May 13, 2026, at 4:30 p.m. ET / 2:30 p.m. MT
Webcast:	The live webcast and replay can be found here.
Register for the call:	Preregistration is required to attend the live call and can be accessed here. A pin code and dial in number will be provided with registration.

A replay of the call will be available after 7:30 p.m. ET and can be accessed here.

About SeaStar Medical

SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. SeaStar Medical’s first commercial product, QUELIMMUNE (SCD-PED), was approved in 2024 by the U.S. Food and Drug Administration (FDA). It is the only FDA approved product for the ultra-rare condition of life-threatening Acute Kidney Injury (AKI) due to sepsis or a septic condition requiring renal replacement therapy (RRT) in critically ill pediatric patients. SeaStar Medical’s Selective Cytopheretic Device (SCD) therapy has been awarded Breakthrough Device Designation for six therapeutic indications by the FDA, enabling the potential for a speedier pathway to approval and preferable reimbursement dynamics at commercial launch. The company is currently conducting the NEUTRALIZE-AKI pivotal clinical trial of its SCD therapy in adult patients with AKI requiring continuous renal replacement therapy, a life-threatening condition with no effective treatment options that impacts over 200,000 adults in the U.S. annually.

For more information visit www.seastarmedical.com or visit us on LinkedIn or X.

Contact:
SeaStar Investor Relations:
IR@SeaStarMed.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will SeaStar Medical (ICU) report Q1 2026 results and how can I listen?

SeaStar Medical will report results after market close on May 13, 2026. According to SeaStar Medical, a live webcast and conference call will start at 4:30 p.m. ET; preregistration is required to obtain dial-in details and a PIN.

What time is the SeaStar Medical (ICU) earnings call on May 13, 2026?

The earnings call is scheduled for 4:30 p.m. ET / 2:30 p.m. MT on May 13, 2026. According to SeaStar Medical, the live webcast and replay links will be provided on the company’s event page after registration.

Do investors need to register to join the SeaStar Medical (ICU) May 13 webcast and call?

Yes. According to SeaStar Medical, preregistration is required to attend the live conference call and to receive the dial-in number and PIN. The company advises registering in advance via the event registration link.

When will the replay of SeaStar Medical's (ICU) Q1 2026 call be available?

A replay will be available after 7:30 p.m. ET on May 13, 2026. According to SeaStar Medical, the replay can be accessed via the same webcast page used for the live event.

Where can shareholders find the SeaStar Medical (ICU) webcast and call materials for May 13, 2026?

Shareholders can find the live webcast, replay, and registration links on SeaStar Medical’s investor website. According to SeaStar Medical, the company will post the webcast link and call access details on its event page.